{"slideshow_credits": null, "snippet": "The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins recently approved for use in the United States.", "abstract": "DealBook Online; Allergan, maker of Botox, says it will buy Kythera Biopharmaceuticals for $2.1 billion.", "section_name": "Business Day", "print_page": "5", "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/06/18/business/dealbook/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion.html", "lead_paragraph": "The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins recently approved for use in the United States.", "headline": {"main": "Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion", "print_headline": "Allergan Deal"}, "_id": "55816fa438f0d81a607270aa", "word_count": "492", "multimedia": [], "pub_date": "2015-06-18T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Allergan Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Kythera Biopharmaceuticals Inc.", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Botox (Drug)", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Stocks and Bonds", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "7"}, {"name": "persons", "value": "Saunders, Brent", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}